← Back to Search

Behavioural Intervention

Wait-list Control for Chronic Pain (ERA Trial)

N/A
Recruiting
Led By Marian Wilson, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age > 18 years
Pain present for more than 3 months more than half the time
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.
Awards & highlights

ERA Trial Summary

"This trial will study the impact of a pain management training program on adults with persistent pain. Nurses will be trained to deliver the program via video conference. The main goal is to see how this program compares

Who is the study for?
This trial is for adults over 18 who have had pain most days for more than three months, can speak English fluently, and are able to attend a one-time online class and complete surveys on the web.Check my eligibility
What is being tested?
The study tests 'Empowered Relief', a single-session video-conferenced program taught by nurses trained in pain management. It aims to see if this program helps reduce problems related to persistent pain like its intensity, interference with life, sleep issues, depression, anxiety, and social isolation compared to those who wait for treatment.See study design
What are the potential side effects?
Since 'Empowered Relief' is an educational intervention rather than a medication or medical procedure, it may not have typical side effects. However, participants might experience emotional discomfort discussing their chronic pain.

ERA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I have had pain for over 3 months, most of the time.
Select...
I am older than 18 years.
Select...
I have had pain for more than 3 months, most of the time.

ERA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain Catastrophizing
Secondary outcome measures
Change in Pain Intensity

ERA Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait-list ControlExperimental Treatment1 Intervention
Participants randomized to the Wait-list Control group will continue their usual pain care for 2 months and complete surveys to compare with the experimental treatment group. After serving as controls, they will be invited to attend the 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.
Group II: Empowered Relief treatmentExperimental Treatment1 Intervention
Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

Find a Location

Who is running the clinical trial?

American Society for Pain Management NursingUNKNOWN
Washington State UniversityLead Sponsor
101 Previous Clinical Trials
56,544 Total Patients Enrolled
2 Trials studying Chronic Pain
373 Patients Enrolled for Chronic Pain
Marian Wilson, PhDPrincipal InvestigatorWashington State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals receiving medical care as part of this research project?

"Indeed, the information on clinicaltrials.gov shows that this trial is currently open for patient enrollment. It was initially listed on 11/1/2023 and most recently revised on 2/4/2024. The study aims to recruit a total of 170 participants from one designated site."

Answered by AI

Are potential participants currently able to apply for enrollment in this study?

"Based on information from clinicaltrials.gov, this research study is actively enrolling participants. The trial was initially listed on 11/1/2023 and last revised on 2/4/2024."

Answered by AI
~57 spots leftby Aug 2024